Zydus Lifesciences Q2 Results FY27: Revenue Up 29.17% to Rs 7,909.60 Cr, PAT Falls to Rs 925.50 Cr

Zydus Lifesciences Ltd (ZYDUSLIFE) Q2 Results FY27 announced on 4 November 2026, covering the company's financial performance for the July to September quarter. Revenue stood at Rs 7,909.60 Cr and PAT at Rs 925.50 Cr, so the Zydus Lifesciences Q2 Results FY27 story pairs a higher top line with a lower bottom line, a combination that makes the full set of numbers worth reading together rather than one headline at a time. The results date makes this one of the first filings of the season for the company.

This Zydus Lifesciences Q2 Results results analysis looks at the Financial Highlights, the disclosed business factors, the FY27 outlook and the risks to watch. It opens with the Financial Highlights table, which lines up this quarter against the same quarter of last year.

Click Here – Get Free Investment Predictions

Zydus Lifesciences Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 7909.6 Cr	Rs 6123.2 Cr	+29.17% YoY
Net Profit (PAT)	Rs 925.5 Cr	Rs 1260.9 Cr	-26.6% YoY

Source: company filing for Zydus Lifesciences Q2 Results FY27, 4 November 2026. Figures in Rs Crore.

Key Takeaways from Zydus Lifesciences Q2 Results: What Stands Out

• Revenue of Rs 7,909.60 Cr compares with Rs 6,123.20 Cr in the year-ago quarter, which is YoY growth of 29.17%.
• Net profit of Rs 925.50 Cr is lower than the Rs 1,260.90 Cr reported a year earlier, a fall of 26.6%.
• The two lines moved in opposite directions, so sales growth did not carry through to net profit in Zydus Lifesciences Q2 Results FY27.
• Return on equity of 19.69% and return on capital employed of 21.39% in FY26 give the longer-term context.
• Net profit margin of 11.7% against 20.6% a year earlier leads into the performance analysis.

Zydus Lifesciences Q2 Results FY27: Performance Analysis

Revenue and net profit pulled apart this quarter. Sales rose from Rs 6,123.20 Cr to Rs 7,909.60 Cr, while net profit slipped from Rs 1,260.90 Cr to Rs 925.50 Cr, so the quarter delivered growth on one line and a decline on the other. The size of the movement is notable on both sides, since sales added close to Rs 1,786.40 Cr while net profit gave up roughly Rs 335.40 Cr.

In this Zydus Lifesciences Q2 Results FY27 results analysis, the gap between the 29.17% revenue rise and the 26.6% net profit fall is the central number. The net profit margin narrowed to 11.7% from 20.6% in the comparison quarter, which shows how much of each rupee of revenue reached net profit.

Readers of Zydus Lifesciences Q2 Results can follow the quarterly results over the next filings to see whether the margin gap closes. The supplied data confirms the movement but does not establish its specific cause, so the disclosed drivers are covered in the business factors that follow.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The disclosed factors behind Zydus Lifesciences Q2 Results FY27 start with revenue, which grew 29.2% year on year to Rs 7,909.60 Cr. This was the strongest part of the quarterly results and the main positive on the page, because a higher top line widens the base from which later profit can be earned.

Return on Equity – Return on equity was 19.69% in FY26. This figure describes how effectively shareholder funds generated profit over the last full financial year and sits behind the current quarter, giving readers a yardstick that is independent of one quarter's swings.

Return on Capital Employed – Return on capital employed was 21.39% in FY26. Together with return on equity, it gives a full-year view of capital efficiency against which the lower net profit of this quarter can be placed.

FY27 Outlook After Zydus Lifesciences Q2 Results

The FY27 outlook will be shaped by whether net profit recovers toward the Rs 1,260.90 Cr level of the year-ago quarter while revenue stays near Rs 7,909.60 Cr. This results analysis shows a clear gap between growth and profit that later quarters can narrow or widen.

Within Zydus Lifesciences Q2 Results FY27, the second quarter is one of four reported periods in FY27. Full-year net profit will depend on the quarters still to come, and the margin of 11.7% is the reference point to compare against, which leads to the risks. Readers who track the company each quarter will find the same comparison useful when the third quarter is declared, because it keeps the year-on-year frame consistent across filings.

Key Risks to Watch After Zydus Lifesciences Q2 Results FY27

Net Profit Decline

Net profit fell 26.6% year on year to Rs 925.50 Cr. Even with revenue growth of 29.17%, a lower profit figure is the first item for investors to track in coming results.

Narrower Net Profit Margin

Net profit margin narrowed to 11.7% from 20.6% in the comparison quarter. In Zydus Lifesciences Q2 Results FY27, this contraction is the clearest sign that YoY growth in sales has not matched profit.

High Debt Level

Debt is high at 0.43 times total assets in FY26. This balance sheet measure is a standing risk factor that investors can weigh alongside the quarter's earnings, and it is separate from the profit movement discussed above.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Zydus Lifesciences Q2 Results FY27 show revenue of Rs 7,909.60 Cr and net profit of Rs 925.50 Cr, a mix of rising sales and falling profit. These quarterly results are best read through the margin change and the FY26 return ratios. Investors should consult a SEBI-registered advisor before acting, and can compare Zydus Lifesciences Q2 Results data on the Univest app.

Frequently Asked Questions on Zydus Lifesciences Q2 Results FY27

What are Zydus Lifesciences Q2 Results FY27?

Ans. Zydus Lifesciences Q2 Results FY27 are the July to September 2026 quarterly results of Zydus Lifesciences, declared on 4 November 2026, with revenue of Rs 7,909.60 Cr and net profit of Rs 925.50 Cr.

What is the results date for Zydus Lifesciences Q2 Results FY27?

Ans. The results date for Zydus Lifesciences Q2 Results FY27 is 4 November 2026, when Zydus Lifesciences declared its Q2 FY27 numbers, which the Quick Answer and the Financial Highlights table both reflect.

What revenue was reported in Zydus Lifesciences Q2 Results FY27?

Ans. Zydus Lifesciences reported revenue of Rs 7,909.60 Cr in Q2 FY27, compared with Rs 6,123.20 Cr a year earlier, as the Financial Highlights table shows in full.

What net profit was reported in Zydus Lifesciences Q2 Results FY27?

Ans. Net profit in Q2 FY27 was Rs 925.50 Cr, compared with Rs 1,260.90 Cr in the same quarter of last year, which the Performance Analysis section explains further.

How much YoY growth did revenue show in Zydus Lifesciences Q2 Results FY27?

Ans. Revenue rose 29.17% year on year in Q2 FY27, while net profit moved the other way, so the Key Takeaways section treats the two lines separately.

Did net profit rise or fall in Zydus Lifesciences Q2 Results?

Ans. Net profit fell 26.6% year on year in Q2 FY27, from Rs 1,260.90 Cr to Rs 925.50 Cr, and the Performance Analysis section sets this against the revenue rise.

What was the net profit margin in Zydus Lifesciences Q2 Results FY27?

Ans. The net profit margin narrowed to 11.7% from 20.6% in the comparison quarter, which means less of each rupee of revenue reached net profit, as the Key Risks section notes.

What was the previous year revenue in Zydus Lifesciences Q2 Results FY27?

Ans. The year-ago quarter reported revenue of Rs 6,123.20 Cr, so the current Rs 7,909.60 Cr is higher by 29.17%, a comparison the Financial Highlights table presents side by side.

What business factors shaped Zydus Lifesciences Q2 Results FY27?

Ans. The disclosed factors are revenue growth of 29.2%, return on equity of 19.69% and return on capital employed of 21.39% in FY26, all listed under Key Business Factors.

What are the key risks after Zydus Lifesciences Q2 Results FY27?

Ans. The disclosed risks are a 26.6% fall in net profit, a narrower margin of 11.7% and debt at 0.43 times total assets in FY26, as the Key Risks section explains.

What is the outlook after Zydus Lifesciences Q2 Results?

Ans. The FY27 outlook depends on whether later quarters narrow the gap between Rs 7,909.60 Cr revenue and Rs 925.50 Cr net profit, which the Outlook section of this article discusses.

Where can I find the complete Zydus Lifesciences Q2 Results FY27 data?

Ans. The complete figures sit in the Financial Highlights table on this page, while the Univest Screener and the Univest app let investors compare the same quarterly results with other companies.